|
 |
 |
 |
 |
 |
 |
- Home
- Join or Change Subscription
- GSI Community
- For New Patients
- About GIST
- Pediatric GIST & Carney Triad
- Treatments
- Ask the Professional
- Learning Center
- Voices of GIST
- Educational Materials
- GIST Support Wiki
- Donate
Sorafenib plus 17-AAG
 | |
 | |
Sorafenib plus 17-AAG
A trial combining sorafenib plus 17-AAG has now closed. Link to NCT00121264 to read about this closed trial of sorafenib (a multi-kinase inhibitor with anti-angiogenic action) plus 17-AAG (a heat shock protein 90 inhibitor).
You can read more about each of the two drugs separately at our pages for sorafenib and 17-AAG.
17-AAG is being combined with other drugs in current trials.
